PMID- 35769408 OWN - NLM STAT- PubMed-not-MEDLINE LR - 20220716 IS - 2671-8790 (Print) IS - 2671-8804 (Electronic) IS - 2671-8790 (Linking) VI - 33 IP - 3 DP - 2019 Sep 30 TI - Clinical significance of donor-specific anti-HLA-DR51/52/53 antibodies for antibody-mediated rejection in kidney transplant recipients. PG - 47-54 LID - 10.4285/jkstn.2019.33.3.47 [doi] AB - BACKGROUND: The presence of donor-specific antibodies (DSAs) to human leukocyte antigen (HLA) increases the risk of antibody-mediated rejection (ABMR) after kidney transplantation (KT). However, the clinical relevance of anti-HLA-DR51/52/53 antibodies remains unclear because of their weak antigen expression. This study evaluated the association between anti-HLA-DR51/52/53 DSAs and ABMR. METHODS: We retrospectively reviewed the single-antigen-bead panel reactive antibody (single PRA) results of 130 patients tested between August 1, 2009 and March 6, 2015, based on clinical necessity after allograft KT. Single PRA analysis was performed using Luminex assay kits (Lifecodes LSA class I and II). We reviewed the clinical course and biopsy results of patients with anti-HLA-DR51/52/53 DSAs. RESULTS: Post-KT DSAs were identified in 89 of the 130 patients (68.5%), with 26 of 32 class I DSAs and 63 of 66 class II DSAs being immunodominant DSAs. Thirteen patients had anti-HLA-DR51/52/53 DSAs. Three patients with anti-HLA-DR51/52/53 immunodominant DSAs alone were diagnosed with biopsy-proven ABMR. One patient who developed anti-HLA-DR DSA 13 days after KT showed a rapid increase in anti-HLA-DR51 DSA and had biopsy-proven ABMR. CONCLUSIONS: Although the expression of the HLA-DR51/52/53 antigen was weak, anti-HLA-DR51/52/53 DSAs might be correlated with biopsy-proven ABMR. Therefore, anti-HLA-DR51/52/53 DSAs must be evaluated as a cause of ABMR after transplantation. CI - Copyright: (c) 2020 The Korean Society for Transplantation. FAU - Park, Borae Geum AU - Park BG AUID- ORCID: 0000-0001-9710-9253 AD - Department of Laboratory Medicine, Severance Hospital, Yonsei University College of Medicine, Seoul, Korea. AD - Department of Laboratory Medicine, Korea University Guro Hospital, Seoul, Korea. FAU - Park, Younhee AU - Park Y AUID- ORCID: 0000-0001-8458-1495 AD - Department of Laboratory Medicine, Severance Hospital, Yonsei University College of Medicine, Seoul, Korea. FAU - Joo, Dong Jin AU - Joo DJ AUID- ORCID: 0000-0001-8405-1531 AD - Department of Surgery, Severance Hospital, Yonsei University College of Medicine, Seoul, Korea. FAU - Huh, Kyu Ha AU - Huh KH AUID- ORCID: 0000-0003-1364-6989 AD - Department of Surgery, Severance Hospital, Yonsei University College of Medicine, Seoul, Korea. FAU - Kim, Myoung Soo AU - Kim MS AUID- ORCID: 0000-0002-8975-8381 AD - Department of Surgery, Severance Hospital, Yonsei University College of Medicine, Seoul, Korea. FAU - Kim, Soon Il AU - Kim SI AUID- ORCID: 0000-0002-0783-7538 AD - Department of Surgery, Severance Hospital, Yonsei University College of Medicine, Seoul, Korea. FAU - Kim, Yu Seun AU - Kim YS AUID- ORCID: 0000-0002-5105-1567 AD - Department of Surgery, Severance Hospital, Yonsei University College of Medicine, Seoul, Korea. FAU - Kim, Hyon-Suk AU - Kim HS AUID- ORCID: 0000-0001-5662-7740 AD - Department of Laboratory Medicine, Severance Hospital, Yonsei University College of Medicine, Seoul, Korea. LA - eng PT - Journal Article PL - Korea (South) TA - Korean J Transplant JT - Korean journal of transplantation JID - 101775609 PMC - PMC9188942 OTO - NOTNLM OT - Antibody mediated rejection OT - Donor specific antibody OT - Human leukocyte antigen EDAT- 2019/09/30 00:00 MHDA- 2019/09/30 00:01 PMCR- 2019/09/30 CRDT- 2022/06/30 02:34 PHST- 2019/03/14 00:00 [received] PHST- 2019/08/12 00:00 [revised] PHST- 2019/08/13 00:00 [accepted] PHST- 2022/06/30 02:34 [entrez] PHST- 2019/09/30 00:00 [pubmed] PHST- 2019/09/30 00:01 [medline] PHST- 2019/09/30 00:00 [pmc-release] AID - KJT-33-3-047 [pii] AID - 10.4285/jkstn.2019.33.3.47 [doi] PST - ppublish SO - Korean J Transplant. 2019 Sep 30;33(3):47-54. doi: 10.4285/jkstn.2019.33.3.47.